Akero Therapeutics (AKRO) Stock Chart & Stock Price History $45.54 -3.58 (-7.29%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$44.64 -0.90 (-1.99%) As of 09:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Akero Therapeutics Stock Price Performance 5 Day Performance-4.63%1 Month Performance-19.27%3 Month Performance+47.28%6 Month Performance+73.16%Year-To-Date Performance+63.70%1 Year Performance+46.57% Receive AKRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AKRO Stock Chart for Tuesday, March, 4, 2025 AKRO Chart by TradingView Akero Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/03/2025$49.12$45.54-7.29%$48.78$45.47877,958 shs$3.18 billion02/28/2025$47.75$49.12+2.87%$49.25$46.31648,276 shs$3.43 billion02/27/2025$47.67$47.75+0.18%$49.51$46.66646,852 shs$3.33 billion02/26/2025$47.47$47.67+0.41%$48.97$46.55975,484 shs$3.33 billion02/25/2025$49.60$47.47-4.29%$49.66$46.87925,274 shs$3.31 billion02/24/2025$51.84$49.60-4.32%$52.18$49.56732,459 shs$3.46 billion02/21/2025$50.58$51.84+2.49%$52.74$51.09851,969 shs$3.62 billion02/20/2025$50.67$50.58-0.18%$51.39$50.12810,688 shs$3.53 billion02/19/2025$49.45$50.67+2.46%$50.76$48.70596,222 shs$3.54 billion02/18/2025$50.52$49.45-2.11%$51.39$49.35995,727 shs$3.45 billion Get the Latest News and Ratings for AKRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/17/2025$50.52$50.52$51.40$49.24875,286 shs$3.53 billion02/14/2025$49.23$50.52+2.62%$51.40$49.24875,286 shs$3.53 billion02/13/2025$49.44$49.23-0.42%$49.92$48.57784,693 shs$3.44 billion02/12/2025$49.95$49.44-1.02%$50.70$48.841.37 million shs$3.45 billion02/11/2025$51.15$49.95-2.35%$51.13$48.901.59 million shs$3.49 billion02/10/2025$54.21$51.15-5.64%$55.81$51.061.48 million shs$3.57 billion02/07/2025$54.95$54.21-1.35%$55.32$53.88851,309 shs$3.78 billion02/06/2025$57.56$54.95-4.53%$57.78$54.32850,203 shs$3.84 billion02/05/2025$56.41$57.56+2.04%$57.66$55.60795,312 shs$4.02 billion02/04/2025$53.85$56.41+4.75%$57.25$53.601.28 million shs$3.94 billion02/03/2025$54.08$53.85-0.43%$54.69$52.631.23 million shs$3.76 billion Related Companies Intra-Cellular Therapies Stock Price Chart Viatris Stock Price Chart Moderna Stock Price Chart Dr. Reddy's Laboratories Stock Price Chart Vaxcyte Stock Price Chart Sarepta Therapeutics Stock Price Chart Ascendis Pharma A/S Stock Price Chart Qiagen Stock Price Chart Roivant Sciences Stock Price Chart Telix Pharmaceuticals Limited American Depositary Shares Stock Price Chart Receive AKRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AKRO) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKRO Stock Alerts